Clinical Trials Logo

Clinical Trial Summary

This is a two cohort, randomized, double blind, single center study to evaluate the effects of Botox Cosmetic (BTX) on sebum protection. Thirty-four female subjects with moderate-to-high skin sebum concentration will be recruited and randomized in a 1:1 ratio to treatment groups.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05138835
Study type Interventional
Source Erevna Innovations Inc.
Contact
Status Completed
Phase N/A
Start date November 11, 2021
Completion date December 11, 2022

See also
  Status Clinical Trial Phase
Completed NCT04917835 - Non-thermal Plasma for Sebum Reduction in Oily Facial Skin N/A
Completed NCT01640028 - Exploratory Study of Intra and Inter-subject Variability in Sebum Excretion Rate N/A
Completed NCT01254162 - Proof of Concept Study of MTC896 Gel to Reduce Sebum Production on the Forehead of Healthy Male Volunteers Phase 2
Completed NCT02597777 - Topical Acetyl Hexapeptide-8 and the Cosmetic Appearance of Oily Skin N/A